ELISA supplementary kit
Quantitative determination of fecal calprotectin is an indication of the severity of bowel inflammation. Also, higher levels of calprotectin in the stool are associated with an increased risk of relapse in patients with inflammatory bowel disease (IBD). Low stool calprotectin levels correlate well with a low risk for intestinal allograft rejection. This assay uses specific monoclonal antibodies to ensure only calprotectin is detected.
News
Events
Newsletter